Evidence map›Paper›PMID 33733644›Full record

ArticleAllergy, asthma & immunology research2021

Safety of Omalizumab During Pregnancy and Breast-Feeding With Assessment of Placental Transfer: A Case Report.

Doriane Majou, Baptiste Moreira, Clémence Martin, Stéphanie Chhun, Jean Marc Treluyer, Vassilis Tsatsaris, Laurent Chouchana

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Allergy, asthma & immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Safety of Biologics for Atopic Diseases During Pregnancy.The journal of allergy and clinical immunology. In practice · 2022
    Review
  3. Urticaria in Pregnancy and Lactation.Frontiers in allergy · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Doriane MajouMaternité Port Royal, Hôpital Cochin, AP-HP. Centre - Université de Paris, Paris, France.ORCID https://orcid.org/0000-0002-0614-8087
Baptiste MoreiraLaboratoire d'Immunologie Biologique, Hôpital Necker-Enfants Malades, AP-HP. Centre - Université de Paris, INEM U1151 Immunorégulation et Immunopathologie, Paris, France.ORCID https://orcid.org/0000-0003-4385-5888
Clémence MartinService de Pneumologie, Hôpital Cochin, AP-HP. Centre - Université de Paris, Paris, France.
Stéphanie ChhunLaboratoire d'Immunologie Biologique, Hôpital Necker-Enfants Malades, AP-HP. Centre - Université de Paris, INEM U1151 Immunorégulation et Immunopathologie, Paris, France.ORCID https://orcid.org/0000-0001-6278-4128
Jean Marc TreluyerCentre Régional de Pharmacovigilance, Service de Pharmacologie, Hôpital Cochin, AP-HP. Centre - Université de Paris, Paris, France.ORCID https://orcid.org/0000-0002-2045-4742
Vassilis TsatsarisMaternité Port Royal, Hôpital Cochin, AP-HP. Centre - Université de Paris, Paris, France.ORCID https://orcid.org/0000-0002-7650-6660
Laurent ChouchanaCentre Régional de Pharmacovigilance, Service de Pharmacologie, Hôpital Cochin, AP-HP. Centre - Université de Paris, Paris, France.ORCID https://orcid.org/0000-0002-9626-3571

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33733644
PMCPMC7984957

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.